Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000698866 | SCV000827555 | pathogenic | Metachromatic leukodystrophy | 2024-07-23 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 150 of the ARSA protein (p.Pro150Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with metachromatic leukodystrophy (PMID: 23845948, 26462614, 30828547). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Pro148Arg. ClinVar contains an entry for this variant (Variation ID: 576385). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ARSA protein function with a positive predictive value of 95%. This variant disrupts the p.Pro150 amino acid residue in ARSA. Other variant(s) that disrupt this residue have been observed in individuals with ARSA-related conditions (PMID: 10381328, 18786133), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. |
Natera, |
RCV000698866 | SCV002081677 | likely pathogenic | Metachromatic leukodystrophy | 2021-06-11 | no assertion criteria provided | clinical testing | |
Gelb Laboratory, |
RCV000698866 | SCV005046632 | not provided | Metachromatic leukodystrophy | no assertion provided | in vitro |